Metformin and ursodeoxycholic acid both fail to improve long COVID recovery in new clinical trial

Submitted by on Wed, 03/04/2026 - 1:41 PM EST

External URL

https://www.acpjournals.org/doi/10.7326/ANNALS-25-04883

ACP Lastest Link Type

Annals of Internal Medicine

Summary

A 2-week course of metformin or UDCA did not significantly improve recovery from PASC.